Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • gene therapy

    Tag: gene therapy

    You Searched For "gene therapy"
    Pfizer, Novartis lead USD 2 billion spending spree on gene therapy production

    Pfizer, Novartis lead USD 2 billion spending spree on gene therapy production

    Medical Dialogues Bureau28 Nov 2019 9:00 AM IST
    New Delhi: Eleven drugmakers led by Pfizer and Novartis have set aside a combined $2 billion to invest in gene therapy manufacturing since 2018,...
    Roche anticipates USFDA nod for SMA drug Risdiplam by early 2020

    Roche anticipates USFDA nod for SMA drug Risdiplam by early 2020

    Medical Dialogues Bureau26 Nov 2019 9:28 AM IST
    Roche, whose drug Risdiplam is seen as a rival for Biogen's Spinraza and Novartis's Zolgensma gene therapy, said the FDA is due to decide by May 24....
    SETBACK: Novartis Zolgensma study halted by USFDA amid safety concerns

    SETBACK: Novartis Zolgensma study halted by USFDA amid safety concerns

    Medical Dialogues Bureau31 Oct 2019 9:45 AM IST
    Novartis shares fell 1% at 0715 GMT, while other European drugmakers rose. Analysts said more information was needed to assess whether these findings...
    Novartis sees gene, cell therapy reaching up to 15pc of total revenue in midterm

    Novartis sees gene, cell therapy reaching up to 15pc of total revenue in midterm

    Medical Dialogues Bureau5 Sept 2019 9:15 AM IST
    ZURICH: Novartis sees cell and gene therapies accounting for up to 15% of its total revenue in the midterm from a much lower level at present, a Swiss...
    Roche, Spark Therapeutics $4.3 billion deal delayed again amid US, UK scrutiny

    Roche, Spark Therapeutics $4.3 billion deal delayed again amid US, UK scrutiny

    Farhat Nasim10 Jun 2019 9:30 AM IST
    Roche said on Monday that both companies received a request for more information from the U.S. Federal Trade Commission in connection with the FTC's...
    Novartis gets USFDA nod for over Rs 13 crore gene therapy Zolgensma

    Novartis gets USFDA nod for over Rs 13 crore gene therapy Zolgensma

    Farhat Nasim25 May 2019 10:00 AM IST
    The Food and Drug Administration on Friday approved the treatment, called Zolgensma, for all children under age 2 who are confirmed by a genetic test...
    Novartis to buy France

    Novartis to buy France's CellforCure to boost cell, gene therapy

    Medical Dialogues Bureau24 Dec 2018 9:00 AM IST
    Novartis, which already has an agreement with CellforCure to help make Kymriah, said it aims to add CellforCure's facilities to a similar factory in...
    Gene therapy for rare form of blindness wins US approval

    Gene therapy for rare form of blindness wins US approval

    Ruby Khatun Khatun21 Dec 2017 10:04 AM IST
    WASHINGTON: U.S. health officials on Tuesday approved the nation's first gene therapy for an inherited disease, a treatment that improves the sight of...
    Gene therapy becomes reality, but at a price tag of 1 million dollar

    Gene therapy becomes reality, but at a price tag of 1 million dollar

    Ruby Khatun Khatun20 Nov 2017 9:45 AM IST
    LONDON: Battle lines are being drawn as the first gene therapy for an inherited condition nears the U.S. market, offering hope for people with a rare...
    Britain backs GSK gene therapy for BUBBLE BOY syndrome

    Britain backs GSK gene therapy for BUBBLE BOY syndrome

    Ruby Khatun Khatun23 Oct 2017 9:32 AM IST
    GlaxoSmithKline's (GSK) gene therapy for the so-called "bubble boy" disease was approved by Britain's healthcare cost watchdog NICE, despite a price...

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok